Anita W. Rijneveld

Also affiliated with Erasmus MC Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies”.

Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies

Blood(2025)10.1182/blood.2025028387

N/A

0.531DataRank · unranked

19 citations

Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel +28 more

The use of race and ethnicity in sickle cell disease research

BMC Medical Research Methodology(2025)10.1186/s12874-025-02513-5

N/A

0DataRank · unranked

2 citations

Minke A.E. Rab, Erik van Werkhoven, Teun B. Petersen, Marjon H. Cnossen, Amade M’charek +3 more